BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28962916)

  • 1. IGF-I regulates HT1080 fibrosarcoma cell migration through a syndecan-2/Erk/ezrin signaling axis.
    Mytilinaiou M; Nikitovic D; Berdiaki A; Papoutsidakis A; Papachristou DJ; Tsatsakis A; Tzanakakis GN
    Exp Cell Res; 2017 Dec; 361(1):9-18. PubMed ID: 28962916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syndecan-2 is a key regulator of transforming growth factor beta 2/Smad2-mediated adhesion in fibrosarcoma cells.
    Mytilinaiou M; Bano A; Nikitovic D; Berdiaki A; Voudouri K; Kalogeraki A; Karamanos NK; Tzanakakis GN
    IUBMB Life; 2013 Feb; 65(2):134-43. PubMed ID: 23297089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging roles of syndecan 2 in epithelial and mesenchymal cancer progression.
    Mytilinaiou M; Nikitovic D; Berdiaki A; Kostouras A; Papoutsidakis A; Tsatsakis AM; Tzanakakis GN
    IUBMB Life; 2017 Nov; 69(11):824-833. PubMed ID: 28940845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal adhesion kinase regulates syndecan-2-mediated tumorigenic activity of HT1080 fibrosarcoma cells.
    Park H; Han I; Kwon HJ; Oh ES
    Cancer Res; 2005 Nov; 65(21):9899-905. PubMed ID: 16267014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
    Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
    Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of receptor for hyaluronic acid-mediated motility (RHAMM) in low molecular weight hyaluronan (LMWHA)-mediated fibrosarcoma cell adhesion.
    Kouvidi K; Berdiaki A; Nikitovic D; Katonis P; Afratis N; Hascall VC; Karamanos NK; Tzanakakis GN
    J Biol Chem; 2011 Nov; 286(44):38509-38520. PubMed ID: 21914806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin inhibits insulin-like growth factor-1-induced cell migration by the suppression of extracellular signal-regulated kinase 1/2 activation, but not Akt in vascular smooth muscle cells.
    Motobayashi Y; Izawa-Ishizawa Y; Ishizawa K; Orino S; Yamaguchi K; Kawazoe K; Hamano S; Tsuchiya K; Tomita S; Tamaki T
    Hypertens Res; 2009 Mar; 32(3):188-93. PubMed ID: 19262481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activated insulin-like growth factor I receptor induces depolarization in breast epithelial cells characterized by actin filament disassembly and tyrosine dephosphorylation of FAK, Cas, and paxillin.
    Guvakova MA; Surmacz E
    Exp Cell Res; 1999 Aug; 251(1):244-55. PubMed ID: 10438590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced syndecan-1 expression stimulates heparin-binding growth factor-mediated invasion in ovarian cancer cells in a urokinase-independent mechanism.
    Matsuzaki H; Kobayashi H; Yagyu T; Wakahara K; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
    Oncol Rep; 2005 Aug; 14(2):449-57. PubMed ID: 16012729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of IGF-1 signaling by genistein: modulation of E-cadherin expression and downregulation of β-catenin signaling in hormone refractory PC-3 prostate cancer cells.
    Lee J; Ju J; Park S; Hong SJ; Yoon S
    Nutr Cancer; 2012; 64(1):153-62. PubMed ID: 22098108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-I induces cyclooxygenase-2 expression via PI3K, MAPK and PKC signaling pathways in human ovarian cancer cells.
    Cao Z; Liu LZ; Dixon DA; Zheng JZ; Chandran B; Jiang BH
    Cell Signal; 2007 Jul; 19(7):1542-53. PubMed ID: 17341442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.
    Pandini G; Mineo R; Frasca F; Roberts CT; Marcelli M; Vigneri R; Belfiore A
    Cancer Res; 2005 Mar; 65(5):1849-57. PubMed ID: 15753383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor I induces proliferation and migration of porcine trophectoderm cells through multiple cell signaling pathways, including protooncogenic protein kinase 1 and mitogen-activated protein kinase.
    Jeong W; Song G; Bazer FW; Kim J
    Mol Cell Endocrinol; 2014 Mar; 384(1-2):175-84. PubMed ID: 24508636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential signaling activation by insulin and insulin-like growth factors I and II upon binding to insulin receptor isoform A.
    Sacco A; Morcavallo A; Pandini G; Vigneri R; Belfiore A
    Endocrinology; 2009 Aug; 150(8):3594-602. PubMed ID: 19443570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by piperine via the inhibition of PKCα/ERK1/2-dependent matrix metalloproteinase-9 expression.
    Hwang YP; Yun HJ; Kim HG; Han EH; Choi JH; Chung YC; Jeong HG
    Toxicol Lett; 2011 May; 203(1):9-19. PubMed ID: 21354279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGFβ and IGF1R signaling activates protein kinase A through differential regulation of ezrin phosphorylation in colon cancer cells.
    Leiphrakpam PD; Brattain MG; Black JD; Wang J
    J Biol Chem; 2018 May; 293(21):8242-8254. PubMed ID: 29599290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ phosphorylation of Akt and ERK1/2 in rat mammary gland, colon, and liver following treatment with human insulin and IGF-1.
    Hvid H; Fels JJ; Kirk RK; Thorup I; Jensen HE; Hansen BF; Oleksiewicz MB
    Toxicol Pathol; 2011 Jun; 39(4):623-40. PubMed ID: 21558470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desmoglein 3 promotes cancer cell migration and invasion by regulating activator protein 1 and protein kinase C-dependent-Ezrin activation.
    Brown L; Waseem A; Cruz IN; Szary J; Gunic E; Mannan T; Unadkat M; Yang M; Valderrama F; O'Toole EA; Wan H
    Oncogene; 2014 May; 33(18):2363-74. PubMed ID: 23752190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syndecan-1 and syndecan-4 are involved in RANTES/CCL5-induced migration and invasion of human hepatoma cells.
    Charni F; Friand V; Haddad O; Hlawaty H; Martin L; Vassy R; Oudar O; Gattegno L; Charnaux N; Sutton A
    Biochim Biophys Acta; 2009 Oct; 1790(10):1314-26. PubMed ID: 19632304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.